A new study published in the journal of Neurology revealed that semaglutide may increase the risk of non-arteritic anterior ...

CDSCO asks SLAs to take strict action against violation of regulations on GLP-1 based weight loss drugs: Gireesh Babu, New Delhi Wednesday, May 20, 2026, 08:00 Hrs [IST] The Centr ...

Side effects like nausea, vomiting, diarrhea and constipation are common soon after starting GLP-1s or increasing the drug’s dosage. A nutrient-dense diet and regular exercise a ...

Weight-loss drugs such as semaglutide are effective at tackling the biological drivers of Alzheimer’s disease, a new study ...

This continuing education course details the role of GLP-1 injectables in managing chronic conditions and overweight/obesity, ...

Men’s Health spoke to Thomas Kruse and Jesper Lau, two chemists responsible for creating the drug that’s revolutionized how ...

GLP-1 receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide agonists are not likely to decrease the ...

As the demand for GLP-1 medication soars, so does the demand for more affordable formulas. In Canada, health regulators took one step to fill that gap by approving a generic version of semaglutide, ...

New research presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows the use of the new GLP-1 ...

By combining novel measures of brain function with a brain-penetrant dual GLP-1/GIP agonist program, NeuraLight and Kariya Pharmaceuticals aim to tackle one of neurodegeneration's central challenges: ...

New research presented at this year’s European Congress on Obesity in Istanbul, Turkey (12-15 May) shows the use of the new ...